2-Bromo-6-fluoro-3-nitropyridine

Catalog No.: 
ACUSZV194
CAS No.: 
1639977-00-6
Molecular Formula: 
C5H2BrFN2O2
Molecular Weight: 
220.99
2-Bromo-6-fluoro-3-nitropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$102.00In stockInquiry
250mg97%$135.00In stockInquiry
1g97%$451.00In stockInquiry
5g97%$1408.00In stockInquiry
10g97%$2030.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-6-fluoro-3-nitropyridine
IUPAC Name2-bromo-6-fluoro-3-nitropyridine
MDL No.MFCD28405391
Molecular FormulaC5H2BrFN2O2
Molecular Weight220.99
SMILESO=[N+](C1=CC=C(F)N=C1Br)[O-]
InChI KeyQWDBPCRXRKMIQG-UHFFFAOYSA-N
SynonymPyridine, 2-bromo-6-fluoro-3-nitro-;2-Bromo-6-fluoro-3-nitropyridine;2-bromo-6-fluoro-3-nitro-pyridine - [B83458]
CAS No.1639977-00-6
PubChem CID118992774

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUSZV194 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSZV194 route product structure diagram
    ACUSZV1941639977-00-6In Stock
Inquiry

2. ACUSZV194 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSZV194 route product structure diagram
    ACUSZV1941639977-00-6In Stock
Inquiry

3. ACUSZV194 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUSZV194 route product structure diagram
    ACUSZV1941639977-00-6In Stock
Inquiry

Comments (0)